All Articles

The new partnership between Manchester City and EV giant BYD is more than a sponsorship—it's a strategic play for European dominance and a new model for sustainability.

Gaming giant The9 is using generative AI to resurrect the iconic TVB drama 'The Greed of Man' as a short drama and an interactive movie game.

Amid a surging aerospace market, StandardAero's upcoming earnings report is highly anticipated after a year of record growth and strategic expansion.

A new Singapore venture aims to solve AI's biggest data jam, but its strategic exclusion of China signals a major geopolitical play in the tech arms race.

A new poll and research find that asking AI 'Are you sure?' rarely improves accuracy, revealing a critical gap between user behavior and AI reliability.

The defense contractor signals a strategic shift after lost contracts and procurement delays slash its 2027 revenue outlook, even as profits beat expectations.

Following a management buyout, the former Delap Wealth Advisory team relaunches as Aerodigm, an independent firm targeting after-tax returns for the ultra-rich.

The digital bank posted 45% net income growth and a 36% credit surge, proving rapid expansion and profitability can coexist in Latin America's fintech wars.

A Spanish court has warned Ryanair officials of criminal liability for defying court orders, a major escalation in its bitter feud with the travel platform.

Corporate apparel maker Unisync Corp. shifts from loss to profit, boosting margins and securing new deals, proving operational efficiency can trump lower sales.

Health Canada grants conditional approval to BioMarin's VOXZOGO, the first drug in the country to target the genetic cause of achondroplasia.

As OneSpaWorld prepares its Q4 results, all eyes are on the wellness giant as a barometer for luxury travel spending and its tech-driven future.

Echodyne is building a $40M facility to meet soaring global demand for advanced radar, aiming to counter drone threats and bolster U.S. manufacturing.

Terex declared a steady dividend, but the real story is its surging stock and a bold forecast, revealing deep confidence in its strategic direction.

NervGen Pharma to unveil data showing its drug NVG-291 provides lasting functional gains for chronic spinal cord injury, a major step forward.

New research proves pocket-sized, AI-powered ultrasound is a game-changer for urgent care, tackling staff shortages and improving patient outcomes.

Consulting firm Sia's new Agent Store moves beyond chatbots, deploying specialized AI agents to automate everything from compliance to crisis management.

Libro seated 11 million guests in 2025, leading a charge against costly reservation platforms with its commission-free, data-centric business model.

Canadian giant Aurora Cannabis launches new high-THC flower and resin products in Australia and New Zealand, aiming to capture a larger share of the booming market.

Vivacom extends its decades-long partnership with Netcracker, investing in a future-ready BSS platform to compete in Bulgaria's dynamic telecom market.